SCHEDULE 13G/A: Balyasny Asset Management Discloses 9.30% Stake in Verastem Inc.

Balyasny Asset Management L.P. and its affiliates have filed an amended Schedule 13G, disclosing a beneficial ownership of 9.30% in Verastem Inc.'s common stock as of March 31, 2025.

Summary

• Balyasny Asset Management L.P. and its affiliated entities (BAM GP LLC, Balyasny Asset Management Holdings LP, Dames GP LLC, and Dmitry Balyasny) have filed an Amendment No. 1 to Schedule 13G.
• The filing discloses their beneficial ownership in Verastem Inc. (Issuer: Verastem Inc., Common Stock, CUSIP 92337C203).
• As of March 31, 2025, the Reporting Persons collectively beneficially own 4,787,975 shares of Verastem Inc. common stock.
• This ownership represents 9.30% of Verastem Inc.'s outstanding common stock, based on 51,486,705 shares outstanding as of March 19, 2025.
• The shares are held with sole voting and sole dispositive power by each reporting person over the stated amount.
• The acquisition of shares was made in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
• Atlas Diversified Master Fund, Ltd. (ADMF), an investment management client of BAM, is noted as the direct holder of 3,945,927 shares, with the right to receive dividends or proceeds from their sale.

Sentiment

Score: 6

Explanation: The disclosure of a 9.30% beneficial ownership stake by Balyasny Asset Management, a well-known investment firm, in Verastem Inc. is generally viewed as a neutral to slightly positive signal, indicating institutional interest without an activist intent.

Positives

• A significant stake (9.30%) by a prominent investment firm like Balyasny Asset Management could be seen as a vote of confidence in Verastem Inc.
• The filing indicates the shares were acquired in the ordinary course of business, suggesting a passive, long-term investment perspective rather than an activist intent to influence control.

Future Outlook

Not applicable. This filing is a disclosure of past ownership, not a forward-looking statement about the issuer's business.

Industry Context

Schedule 13G filings are routine disclosures by institutional investors who acquire more than 5% of a company's voting class of securities, but do not intend to influence or control the company. This filing indicates Balyasny Asset Management's passive investment in Verastem Inc., a common practice for large asset managers building diversified portfolios.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional stake may increase investor confidence and potentially influence trading volume or share price.

Key Dates

Keywords

Verastem Inc., Balyasny Asset Management, Schedule 13G, beneficial ownership, common stock, investment, institutional investor, SEC filing, equity stake, 92337C203